NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $44.52 +0.37 (+0.83%) As of 10:45 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Guardian Pharmacy Services Stock (NYSE:GRDN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GRDN alerts:Sign Up Key Stats Today's Range$44.36▼$45.2550-Day Range$37.05▼$48.1152-Week Range$23.14▼$48.33Volume19,219 shsAverage Volume419,912 shsMarket Capitalization$2.22 billionP/E Ratio43.25Dividend YieldN/APrice Target$44.50Consensus RatingModerate Buy Company Overview Guardian Pharmacy Services, Inc. is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings. The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments. Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S. markets. The company was established in the 2000s and has expanded its network through a combination of organic growth and partnerships or acquisitions involving regional pharmacy operators.AI Generated. May Contain Errors. Read More Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 31% of companies evaluated by MarketBeat, and ranked 780th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingModerate Buy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and no sell ratings.Upside/DownsideThe consensus price target for Guardian Pharmacy Services is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageGuardian Pharmacy Services has only been the subject of 3 research reports in the past 90 days.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth14.29% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to grow by 14.29% in the coming year, from $1.19 to $1.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardian Pharmacy Services is 42.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.04.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardian Pharmacy Services is 42.89, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.10.Price to Earnings Growth RatioGuardian Pharmacy Services has a PEG Ratio of 2.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGuardian Pharmacy Services has a P/B Ratio of 12.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Guardian Pharmacy Services' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.11% of the float of Guardian Pharmacy Services has been sold short.Short Interest Ratio / Days to CoverGuardian Pharmacy Services has a short interest ratio ("days to cover") of 9.41.Change versus previous monthShort interest in Guardian Pharmacy Services has recently increased by 1.16%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.43 News SentimentGuardian Pharmacy Services has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for GRDN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsGuardian Pharmacy Services has minimal institutional ownership at this time.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRDN Stock News HeadlinesGuardian Pharmacy Services (NYSE:GRDN) Given New $51.00 Price Target at Truist FinancialSeptember 21 at 9:06 AM | americanbankingnews.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 21 at 4:29 AM | americanbankingnews.comA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.September 22 at 1:00 AM | TradeSmith (Ad)Guardian Pharmacy Services (NYSE:GRDN) Downgraded by Wall Street Zen to HoldSeptember 19 at 1:06 AM | americanbankingnews.comGuardian Pharmacy Implements Insider Lock-Up to Support StabilitySeptember 10, 2026 | tipranks.comOppenheimer Sticks to Its Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)September 9, 2026 | theglobeandmail.comStephens Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)September 9, 2026 | theglobeandmail.comGuardian Pharmacy Services Buys Assets From Nautilus PharmacySeptember 3, 2026 | finance.yahoo.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $30.01 at the beginning of the year. Since then, GRDN shares have increased by 47.2% and is now trading at $44.18. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. The firm earned $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a trailing twelve-month return on equity of 29.97% and a net margin of 4.50%. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Guardian Pharmacy Services' top institutional investors include Wellington Management Group LLP (3.47%), Braun Stacey Associates Inc. (0.68%), Ranger Investment Management L.P. (0.35%) and Globeflex Capital L P (0.09%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, Kendall Forbes, John Ackerman, Equity Fund LP Cardinal, David K Morris and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings8/06/2026Today9/22/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (11m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 GRDN's financial health is in the Green zone, according to TradeSmith. GRDN has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,600Year Founded2004Price Target and Rating Average Price Target for Guardian Pharmacy Services$44.50 High Price Target$51.00 Low Price Target$36.00 Potential Upside/Downside-0.1%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$1.03 Trailing P/E Ratio43.25 Forward P/E Ratio37.42 P/E Growth2.33Net Income$49.22 million Net Margins4.50% Pretax Margin6.55% Return on Equity29.97% Return on Assets16.18% Debt Debt-to-Equity RatioN/A Current Ratio1.65 Quick Ratio1.33 Sales & Book Value Annual Sales$1.45 billion Price / Sales1.53 Cash Flow$1.25 per share Price / Cash Flow35.72 Book Value$3.44 per share Price / Book12.94Miscellaneous Outstanding Shares49,800,000Free Float33,385,000Market Cap$2.22 billion OptionableN/A Beta0.06 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:GRDN) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersChina's dominance in rare earth processing sparks new defense rulesOn January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adve...The Tomorrow Investor | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc. (OTCQB: VDTA) is targeting the infrastructure layer beneath the AI boom, from GPU hardware ...Trading Wire | SponsoredInside Nevada's 60 Million Ounce Gold CorridorBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...Wall Street Logic | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredPass by August 7… or wait until 2027?On August 14, federal regulators cleared a national trust bank tied to the Trump family's crypto venture. W...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
